| Joseph Gibbons, | |
|
155 Memorial Dr, Pinehurst, NC 28374-8710 | |
| (910) 715-2164 | |
| Not Available |
| Full Name | Joseph Gibbons |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 22 Years |
| Location | 155 Memorial Dr, Pinehurst, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134173933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2008-00195 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Firsthealth Home Care | West end, NC | Home health agency |
| Firsthealth Moore Regional Hospital | Pinehurst, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fhpg Llc | 9537481569 | 164 |
News Archive
For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).
Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
Half of all patients who undergo myocardial infarction (heart attack) are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who believe that the illness has a large impact on their life. These are the conclusions of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden.
› Verified 9 days ago
| Entity Name | Firsthealth Of The Carolinas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548276389 PECOS PAC ID: 8820909377 Enrollment ID: O20031108000016 |
News Archive
For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).
Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
Half of all patients who undergo myocardial infarction (heart attack) are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who believe that the illness has a large impact on their life. These are the conclusions of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden.
› Verified 9 days ago
| Entity Name | Columbus Regional Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508001009 PECOS PAC ID: 6608924931 Enrollment ID: O20090424000511 |
News Archive
For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).
Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
Half of all patients who undergo myocardial infarction (heart attack) are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who believe that the illness has a large impact on their life. These are the conclusions of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden.
› Verified 9 days ago
| Entity Name | Scotland Regional Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972829562 PECOS PAC ID: 2365573185 Enrollment ID: O20100623000242 |
News Archive
For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).
Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
Half of all patients who undergo myocardial infarction (heart attack) are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who believe that the illness has a large impact on their life. These are the conclusions of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden.
› Verified 9 days ago
| Entity Name | Fhpg Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336154129 PECOS PAC ID: 9537481569 Enrollment ID: O20141202002644 |
News Archive
For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).
Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
Half of all patients who undergo myocardial infarction (heart attack) are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who believe that the illness has a large impact on their life. These are the conclusions of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Gibbons, 155 Memorial Dr, Pinehurst, NC 28374-8710 Ph: (910) 715-2164 | Joseph Gibbons, 155 Memorial Dr, Pinehurst, NC 28374-8710 Ph: (910) 715-2164 |
News Archive
For the estimated 220,000 men who will be diagnosed with prostate cancer this year, deciding on a method of treatment can be a challenge. Some with early-stage cancer pursue a "wait and watch" option, also called active surveillance, while others with more severe cancer immediately pursue surgery, including prostatectomy (removal of the prostate).
Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's NurOwn™ autologous adult stem cell product candidate for the treatment of amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
Half of all patients who undergo myocardial infarction (heart attack) are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who believe that the illness has a large impact on their life. These are the conclusions of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden.
› Verified 9 days ago
Wesley C Greene, PA-C Hospitalist Medicare: Medicare Enrolled Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-2164 Fax: 910-715-4493 | |
Ranjeet Kumar Goswami, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-2164 Fax: 910-715-4493 | |
Eric Preston Waddington, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-2164 | |
Matthew B Holler, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-2164 Fax: 910-715-4493 | |
Kristy Rae Boan, PA-C Hospitalist Medicare: Medicare Enrolled Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-2164 Fax: 910-715-1926 | |
Suzanne L Wilson, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 205 Page Road, Pinehurst, NC 28374 Phone: 910-295-5511 Fax: 910-295-5481 |